HUDECEK; Michael

Patent Applications and Registrations

Patent applications and USPTO patent grants for HUDECEK; Michael.The latest application filed is for "ultramodular igg3-based spacer domain and multi-function site for implementation in chimeric antigen receptor design".

Company Profile

6.9.20

HUDECEK; Michael - Hochberg DE
Hudecek; Michael - Leipzig DE
HUDECEK; Michael - Seattle WA US

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Ultramodular Igg3-based Spacer Domain And Multi-function Site For Implementation In Chimeric Antigen Receptor Design App 20220306719 - HUDECEK; Michael ; et al.	2022-09-29
Cell Penetrating Transposase App 20220145332 - HUDECEK; Michael ; et al.	2022-05-12
Ror1-specific Chimeric Antigen Receptors (car) With Humanized Targeting Domains App 20220064258 - HUDECEK; Michael ; et al.	2022-03-03
ROR1-specific chimeric antigen receptors (CAR) with humanized targeting domains Grant 11,149,073 - Hudecek , et al. October 19, 2	2021-10-19
Method and compositions for cellular immunotherapy Grant 11,065,278 - Riddell , et al. July 20, 2	2021-07-20
Control And Modulation Of The Function Of Gene-modified Chimeric Antigen Receptor T Cells With Dasatinib And Other Tyrosine Kinase Inhibitors App 20210169880 - HUDECEK; Michael ; et al.	2021-06-10
Method And Compositions For Cellular Immunotherapy App 20210052649 - Jensen; Michael C. ; et al.	2021-02-25
Method and compositions for cellular immunotherapy Grant 10,869,889 - Jensen , et al. December 22, 2	2020-12-22
Method and compositions for cellular immunotherapy Grant 10,780,118 - Jensen , et al. Sept	2020-09-22
Method and compositions for cellular immunotherapy Grant 10,736,918 - Jensen , et al. A	2020-08-11
Use Of Flt3 Car-t Cells And Flt3 Inhibitors To Treat Acute Myeloid Leukemia App 20200206266 - HUDECEK; Michael ; et al.	2020-07-02
Cd19cart Cells Eliminate Myeloma Cells That Express Very Low Levels Of Cd19 App 20200209240 - EINSELE; Hermann ; et al.	2020-07-02
Method And Compositions For Cellular Immunotherapy App 20200078405 - Jensen; Michael C. ; et al.	2020-03-12
Ror1-specific Chimeric Antigen Receptors (car) With Humanized Targeting Domains App 20200040058 - HUDECEK; Michael ; et al.	2020-02-06
Compositions And Methods For Transplant Recipient Conditioning App 20190350980 - PAPAYANNOPOULOU; Thalia ; et al.	2019-11-21
A Method For High Level And Stable Gene Transfer In Lymphocytes App 20190169637 - HUDECEK; Michael ; et al.	2019-06-06
Method And Compositions For Cellular Immunotherapy App 20180296602 - RIDDELL; Stanley R. ; et al.	2018-10-18
Method And Compositions For Cellular Immunotherapy App 20180200298 - Jensen; Michael C. ; et al.	2018-07-19
Method and compositions for cellular immunotherapy Grant 9,987,308 - Riddell , et al. June 5, 2	2018-06-05
Method For The Treatment Of Obesity App 20160095883 - Riddell; Stanley R. ; et al.	2016-04-07
Method And Compositions For Cellular Immunotherapy App 20150306141 - Jensen; Michael C. ; et al.	2015-10-29
Method for the treatment of obesity Grant 9,163,258 - Riddell , et al. October 20, 2	2015-10-20
Method And Compositions For Cellular Immunotherapy App 20140314795 - Riddell; Stanley R. ; et al.	2014-10-23
Method For The Treatment Of Obesity App 20130202622 - Riddell; Stanley R. ; et al.	2013-08-08

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.